2 terminated. 2 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 2 | Terminated 2 |
Follow Sofosbuvir: new trials by email Literature Review of Sofosbuvir trials Research Report on Sofosbuvir
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Improving Response to Immunotherapy in Patients With Advanced Hepatocellular Carcinoma and Chronic Hepatitis C Virus Infection With Direct-Acting Antiviral Therapy Bevacizumab, Atezolizumab, Sofosbuvir - Liver Cancer | Phase 4 | Terminated | M.D. Anderson Cancer Center | 2 | 2023-03-17 | 2024-12-31 |
| Oral Hepatitis C Treatment for Indolent Lymphoma (OPTImaL) Study sofosbuvir/ledipasvir, sofosbuvir, Ribavirin - Liver Disease | Phase 4 | Terminated | University of Texas Southwestern Medical Center | 1 | 2016-02-25 | 2019-01-08 |
Hepatitis C (1) · Liver Diseases (1) · Liver Neoplasms (1) · Lymphoma, Non-Hodgkin (1)
M.D. Anderson Cancer Center (1) · University of Texas Southwestern Medical Center (1)
United States (2)
Harrys A. Torres, MD (1) · Mamta K. Jain, MD (1)